Vimarsana
Biggest News Aggregation in the World

Page 45 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sofinnova Partners Today - Breaking & Trending Today

Gide, counsel to Apollo on its strategic and financial partnership with Sofinnova - Vimarsana News

Gide, counsel to Apollo on its strategic and financial partnership with Sofinnova

Gide has advised Apollo alongside Paul, Weiss, Rifkind, Wharton & Garrison LLP on the conclusion of a partnership agreement with a view to acquiring a minority equity interest in European venture capital firm Sofinnova Partners, which specialises in life sciences and is based in Paris, London and Milan, and to committing to invest to Sofinnova's investment funds.

Source: gide.com
SITRYX THERAPEUTICS TO PARTICIPATE IN WELLS FARGO VIRTUAL PRIVATE BIOTECH SYMPOSIUM - Vimarsana News

SITRYX THERAPEUTICS TO PARTICIPATE IN WELLS FARGO VIRTUAL PRIVATE BIOTECH SYMPOSIUM

/PRNewswire/ -- Sitryx Therapeutics Ltd (the "Company"), a biopharmaceutical company pioneering the field of immunometabolism, today announced that company...

Apollo takes stake in life sciences VC firm Sofinnova Partners - Vimarsana News

Apollo takes stake in life sciences VC firm Sofinnova Partners

Apollo Global Management will take a minority equity stake in European venture capital firm Sofinnova Partners.

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences - Vimarsana News

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences

Apollo expands its growth ecosystem by acquiring a minority stake in pioneering life sciences venture capital firm and providing up to €1 billion of capital commitments Sofinnova Partners poised

Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform - Vimarsana News

Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform

Milan-based NanoPhoria raised €3.5 million in seed financing to advance its pre-clinical stage treatment for heart failureMILAN, ITALY / ACCESSWIRE / May 12, 2022 / Sofinnova Partners, a leading European